ELISA
Biovica Inks Master Service Agreement for Oncology-Use Cell Proliferation Assay
The firm's DiviTum TKa assay will be used in drug development studies, and the firm said the deal could lead to the development of the test as a companion diagnostic.
The automated instrument has been available for research use, but its target market will be expanded to include clinical diagnostic applications in the coming months.
The firm plans to file for regulatory approval of its first test, a chemiluminescent ELISA for respiratory disease, as early as the first quarter of 2024.
Dynex Technologies to Distribute Tecan Immunoassay Products in US
Dynex offers a variety of fully automated ELISA microplate instruments that can run Tecan's ELISA and chemiluminescence assays.
OncoHost Raises $35M in Series C Financing
The Israeli firm will use the funds to expand its PROPHETIC trial and support the US commercial launch of the Prophet platform.
Mar 14, 2022
CardiNor Nabs CE Mark for Cardiovascular Risk Test
Mar 19, 2021
Mar 3, 2021
Feb 19, 2021
Feb 11, 2021
Eurofins Gets CE Mark for Coronavirus Antibody Test
Feb 10, 2021
VolitionRx Prices $20M Public Offering
Jan 4, 2021
Oct 28, 2020
Biodesix Prices $72M IPO
Oct 23, 2020